© BusinessWire
10.11.2025
INSP
LISTED
NYSE
INSP BREAKING: Inspire Medical Systems, Inc. Inspire V Delays Trigger Securities Fraud Class Action after Stock Drops 32% -- Investors are Urged to Contact BFA Law
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.
If you invest...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ASRT
LISTED
NASDAQ
Assertio Reports Third Quarter 2025 Financial Results
News Preview
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the third quarter ended September 30, 2025.
Mark Reisenauer, Chief Executive Officer, stated: “In the...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INSPIRE MEDICAL SYSTEMS, INC. (INSP), CONTACT THE LAW OFFICES OF HOWARD G....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
10.11.2025
INSP
LISTED
NYSE
Securities Fraud Investigation Into Inspire Medical Systems, Inc. (INSP) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON INSPIRE MEDICAL SYSTEMS, INC. (INSP), CLICK HERE TO INQUIRE ABOUT POTENTIAL...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
10.11.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
GMAB
LISTED
CPH
Genmab Provides Certain Information Disclosed in Connection with Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ANAB
LISTED
NASDAQ
Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis
News Preview
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that investigational rosnilimab was safe and well tolerated but did not meet the primary endpoint of mean change from baseline in modified Mayo Score (mMS) o...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
BAYN
LISTED
XETR
Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science
News Preview
Today, on World Science Day, Bayer is proud to launch its “Science Delivers” campaign, a nationwide initiative celebrating how science delivers answers, hope, and progress for all Americans—every day, in the moments that matter most.
From the medicine that keeps us healthy to the technology that connects and helps feed us, to the innovations tha...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
MDGL
LISTED
NASDAQ
Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis
News Preview
CONSHOHOCKEN, Pa., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced positive two-year data from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
GMAB
LISTED
CPH
Genmab Announces Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes and Syndication of New Senior Secured Term Loan Facility
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
GNFT
LISTED
EURONEXT
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 10, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announces a research collaboration with EVerZom to expand its Acute-On-Chronic Lier Fail...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
10.11.2025
GNFT
LISTED
EURONEXT
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 10, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today presents promising new preclinical data in ACLF at The Liver Meeting® 2025 with nitazoxa...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
NKTR
LISTED
NASDAQ
New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
News Preview
Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo in patients who had atopic dermatitis and a history of asthma
Extended dosing with rezpegaldesleukin q2w supports 24-week induction peri...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
SOBI
LISTED
STO
Clinically meaningful pivotal study results for olezarsen in sHTG presented as a late breaker at AHA Scientific Sessions
News Preview
STOCKHOLM, Nov. 8, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that, the TIMI Study Group today has presented positive results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG) at the American Heart Association 2025 Scientific Sessions. The s...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2025
INSP
LISTED
NYSE
Rosen Law Firm Urges Inspire Medical Systems, Inc. (NYSE: INSP) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”). Inspire Medical is a medical technology company.
For more information, submit a f...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
INSP
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Com...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
INSP
LISTED
NYSE
Robbins Geller Rudman & Dowd LLP Announces a Class Action Lawsuit Has Been Filed Against Inspire Medical Systems, Inc. (INSP)
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned Cit...
Themefolio
Profiler
Peergroup
© ActuNews
07.11.2025
ALTHX
LISTED
EURONEXT
THERANEXUS : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital
News Preview
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital
Lyon, France - 7 novembre 2025, 18h00 CEST – THX Pharma (Theranexus), société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, publie aujourd'hui le nombre d'actions composant son capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
FAGR
LISTED
EURONEXT
Fagron’s share buy-back program: Weekly update
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 7 November 2025 – 6PM CET...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Presents a Poster on OSE-Cytomask®, a Novel “Cis-Demasking” Cytokine Technology to Increase Therapeutic Index of Immunocytokines
News Preview
OSE Immunotherapeutics Presents a Poster on OSE-Cytomask®, a Novel
“Cis-Demasking” Cytokine Technology to Increase Therapeutic Index of Immunocytokines...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
IBAB
LISTED
EURONEXT
IBA – Regulated information
News Preview
November 7th, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
BAVA
LISTED
CPH
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
News Preview
COPENHAGEN, Denmark, November 7, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5,13% of the shares and voting rights in Bavarian Nordic A/S as of October 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ASND
LISTED
NASDAQ
New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism
News Preview
COPENHAGEN, Denmark, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that a new pooled analysis showed sustained and clinically meaningful improvements in renal function in adults with hypoparathyroidism treated with TransCon PTH (palopegteriparatide) through Year 3 of the Company’s Phase 2 PaTH Forward and Ph...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ORY
LISTED
BME
ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025
News Preview
MADRID and CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today reported financial results for the nine months ended September 30, 2025 and provided a corporate update on recent developments....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
IMCR
LISTED
NASDAQ
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
News Preview
Single ascending dose data show IMC-I109V has manageable safety profile and antiviral activity...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
INSP
LISTED
NYSE
Grant & Eisenhofer Files Class Action Lawsuit Against Inspire Medical Systems, Inc.
News Preview
Today, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of City of Pontiac Reestablished General Employees’ Retirement System against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) and three of the Company’s senior executives, including CEO Timothy Herbert, CFO Richard Buchholz, and Chief Strategy and Growth O...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
NKTR
LISTED
NASDAQ
Nektar Therapeutics Reports Third Quarter 2025 Financial Results
News Preview
SAN FRANCISCO, Nov. 6, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2025.
C...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
MNMD
LISTED
NASDAQ
MindMed Reports Q3 2025 Financial Results and Business Updates
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported financial results for the third quarter ended September 30, 2025 and provided business updates.
“2025 continues to be a year of strong execut...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
BAYN
LISTED
XETR
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
News Preview
The Supervisory Board of Bayer AG has appointed Dr. Judith Hartmann to the company’s Board of Management, effective March 1, 2026. She will succeed Wolfgang Nickl as the company’s Chief Financial Officer (CFO) on June 1, 2026, following his planned retirement at the end of May 2026. Dr. Hartmann is currently an Operating Partner at Sandbrook Capit...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ZEAL
LISTED
CPH
Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results
News Preview
Press Release – No. 15 / 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
CHEMM
LISTED
CPH
Growth in revenue and operating profit
News Preview
Trading statement for Q1 2025/26 (1 July - 30 September 2025)...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
GMAB
LISTED
CPH
Genmab Announces Financial Results for the Nine Months of 2025
News Preview
November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
BAYN
LISTED
XETR
KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
News Preview
Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from baseline over six months by 25% compared to placebo in patients with type 1 diabetes (T1D) and chronic kidney disease (CKD) who were receiving standard of c...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ZLAB
LISTED
NASDAQ
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the third quarter of 2025, along with recent product highlights and corporate updates.
“Zai Lab is entering the next phase of our growth, powered by the rapid advancement of our global pipeline and supported by a commercially profitable and scalable business in China...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
IMCR
LISTED
NASDAQ
Immunocore reports third quarter financial results and provides a business update
News Preview
Immunocore reports third quarter financial results and provides a business update...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
TFX
LISTED
NYSE
Teleflex Announces Quarterly Dividend
News Preview
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2025, to shareholders of record at the close of business on November 14, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
TFX
LISTED
NYSE
Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
News Preview
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 28, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
EHAB
LISTED
NYSE
Enhabit Reports Third Quarter 2025 Financial Results
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended Sept. 30, 2025.
“Our third quarter results reflect strong execution on our core strategic priorities, with year-over-year growth in revenue, census and Adjusted EBITDA,” said Barb Jacobsmeyer, president...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
1SXP
LISTED
XETR
Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma
News Preview
SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma
Andreas Reisse to retire as CEO of SCHOTT Pharma as planned
Christian Mias, Executive Vice President of SCHOTT’s Electronic Packaging Business Unit, appointed as new CEO of SCHOTT Pharma effective May 1st, 2026
Seamless leadership transition ensured
The Supervisory ......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
1SXP
LISTED
XETR
Christian Mias wird Nachfolger von Andreas Reisse als CEO von SCHOTT Pharma
News Preview
SCHOTT Pharma: Christian Mias wird Nachfolger von Andreas Reisse als CEO von SCHOTT Pharma
Andreas Reisse tritt wie geplant als CEO von SCHOTT Pharma in den Ruhestand
Christian Mias, derzeit Executive Vice President der Business Unit Electronic Packaging bei SCHOTT, wird zum 1. Mai 2026 zum neuen CEO von SCHOTT Pharma ernannt
Eine nahtlose Überg......
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
GMAB
LISTED
CPH
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London
News Preview
Media ReleaseCOPENHAGEN, Denmark; November 5, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan Van de Winkel and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Jefferies Global Healthcare Conference in London at 12:00 PM GMT (7:00 AM EST) on November 19, 2025. A webcast of the fir...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
1SXP
LISTED
XETR
Christian Mias wird Nachfolger von Andreas Reisse als CEO
News Preview
Der Aufsichtsrat der SCHOTT Pharma Management AG hat heute Dr. Christian Mias mit Wirkung zum 1. Mai 2026 zum neuen Chief Executive Officer (CEO) von SCHOTT Pharma bestellt. Er folgt auf Andreas Reisse, der planmäßig Ende April 2026 in den Ruhestand gehen wird. Dr. Christian Mias ist seit 2007 in verschiedenen Führungspositionen innerhalb der SCHOT......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
1SXP
LISTED
XETR
Christian Mias to succeed Andreas Reisse as CEO
News Preview
The Supervisory Board of SCHOTT Pharma Management AG has today appointed Christian Mias as the new Chief Executive Officer (CEO) of SCHOTT Pharma, effective May 1, 2026. He will succeed Andreas Reisse, who will retire as planned at the end of April 2026. Christian Mias has held various management positions within the SCHOTT Group since 2007, most r......
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
SOBI
LISTED
STO
Sobi to present New One-Year Data on pegcetacoplan's efficacy in C3G and primary IC-MPGN and new outcome data on NASP at ASN Kidney Week
News Preview
STOCKHOLM, Nov. 5, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that data on Aspaveli/Empaveli in C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) and NASP in uncontrolled gout will be presented at ASN Kidney Week 2025, 5-9 November in Houston, Texas....
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
TEM
LISTED
NASDAQ
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025. The meeting is taking place November 5 - 9 at the Gaylord National Convention Center in National...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
MNMD
LISTED
NASDAQ
MindMed to Participate in Upcoming Investor Conferences
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:
Stifel 2025 Healthcare Conference
Fo...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
SKYE
LISTED
NASDAQ
Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain
News Preview
During 12-week post-treatment period, nimacimab plus semaglutide blunts weight regain compared to semaglutide alone in subset analysis During 12-week post-treatment period, nimacimab plus semaglutide blunts weight regain compared to semaglutide alone in subset analysis...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
CELC
LISTED
NASDAQ
Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call
News Preview
MINNEAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday, November 12, 2025. Management will host a webcast/t...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
LIVN
LISTED
NASDAQ
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the third quarter ended September 30, 2025 and raised full-year 2025 guidance.
Financial Summary and Highlights(1)
Third-quarter revenue of $357.8 million increased 12.5% on a reported basis, 11.0% on a constant-currency basis, and 12.5% on an o...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
RXRX
LISTED
NASDAQ
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
SALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
RXRX
LISTED
NASDAQ
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
News Preview
Co-Founder and CEO Chris Gibson to Transition to Chairman of the Board; Najat Khan to be named Chief Executive Officer and President Co-Founder and CEO Chris Gibson to Transition to Chairman of the Board; Najat Khan to be named Chief Executive Officer and President...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
MOB
LISTED
STO
Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential
News Preview
STOCKHOLM, Nov. 5, 2025 /PRNewswire/ -- Moberg Pharma AB (publ) has entered into an exclusive licensing agreement with Karo Healthcare AB regarding the commercialization of MOB-015 (Terclara®) in Europe. The agreement comprises 19 European markets, enabling a coordinated launch across all key EU markets under the...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
MOB
LISTED
STO
Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential
News Preview
STOCKHOLM, Nov. 5, 2025 /PRNewswire/ -- Moberg Pharma AB (publ) has entered into an exclusive licensing agreement with Karo Healthcare AB regarding the commercialization of MOB-015 (Terclara®) in Europe. The agreement comprises 19 European markets, enabling a coordinated launch across all key EU markets under the...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
SECT_B
LISTED
STO
Top-rated Canadian healthcare provider adopts Sectra's enterprise imaging as a cloud solution for enhanced patient care
News Preview
LINKÖPING, Sweden and MISSISSAUGA, ON, Nov. 5, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is implementing its enterprise imaging as a fully managed cloud solution at Southlake Health in Canada. This will streamline workflows and facilitate collaboration wi...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
EVT
LISTED
XETR
Continued strong execution on strategic priorities
News Preview
Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand; Just – Evotec Biologics ("JEB"; +11.3%) above-expectation; further accelerating growth on non-Sandoz / non-DOD business
Strong scientific advancements of co-developed asset pipeline: Expecting up to four mo......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
EVT
LISTED
XETR
Weiterhin konsequente Umsetzung strategischer Prioritäten
News Preview
Konzernumsatz von 535,1 Mio. € (-7,1 %); Discocery & Preclinical Development-Segment ("D&PD", -12,3 %) mit weiterhin zurückhaltender Nachfrage; Just – Evotec Biologics ("JEB", +11,3 %) übertrifft Erwartungen; weiter beschleunigtes Wachstum außerhalb der Kooperationen mit Sandoz und dem US-amerikanischen Verteidigungsministerium Depa......
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
BAVA
LISTED
CPH
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
News Preview
COPENHAGEN, Denmark, November 5, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4.92% of the shares and voting rights in Bavarian Nordic A/S as of October 30, 2025....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.11.2025
EVT
LISTED
XETR
Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities
News Preview
Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec Biologics ("JEB"; +11.3%) above-expectation; further accelerating growth on non-Sandoz / non-DOD businessStrong scientific advancements of co-developed asset pipeline: Expecting u...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
